Skip to main content

Dodge & Cox

SEC CIK
0000200217
Latest filing
Aug 13, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
55,949
Value
$10.6M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AZN by Dodge & Cox, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202655,949$10.6M<0.1%−1,525−2.7%ReducedHolders
Q1 202657,474$11.3M<0.1%−3,048−5.0%ReducedConverted for a 1-for-2 splitHolders
Q4 2025121,043$11.1M<0.1%−16,445−12.0%ReducedHolders
Q3 2025137,488$10.5M<0.1%00.0%UnchangedHolders
Q2 2025137,488$9.61M<0.1%+1,348+1.0%AddedHolders
Q1 2025136,140$10.0M<0.1%−7,570−5.3%ReducedHolders
Q4 2024143,710$9.42M<0.1%−5,325−3.6%ReducedHolders
Q3 2024149,035$11.6M<0.1%−750−0.5%ReducedHolders
Q2 2024149,785$11.7M<0.1%−5,500−3.5%ReducedHolders
Q1 2024155,285$10.5M<0.1%−390−0.3%ReducedHolders
Q4 2023155,675$10.5M<0.1%−1,650−1.0%ReducedHolders
Q3 2023157,325$10.7M<0.1%−39,250−20.0%ReducedHolders
Q2 2023196,575$14.1M<0.1%−26,850−12.0%ReducedHolders
Q1 2023223,425$15.5M<0.1%−84,900−27.5%ReducedHolders
Q4 2022308,325$20.9M<0.1%−78,040−20.2%ReducedHolders
Q3 2022386,365$21.2M<0.1%−116,124−23.1%ReducedHolders
Q2 2022502,489$33.2M<0.1%−304,337−37.7%ReducedHolders
Q1 2022806,826$53.5M<0.1%−11,069−1.4%ReducedHolders
Q4 2021817,895$47.6M<0.1%−25,970−3.1%ReducedHolders
Q3 2021843,865$50.7M<0.1%−30,161−3.5%ReducedHolders
Q2 2021874,026$52.4M<0.1%−16,250−1.8%ReducedHolders
Q1 2021890,276$44.3M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.